GlaxoSmithKline's bid to tackle neglected diseases receives a muted response from the rest of the industry.
Links:
[1] http://admin.indiaenvironmentportal.org.in/feature-article/drug-patent-plan-gets-mixed-reviews
[2] http://admin.indiaenvironmentportal.org.in/category/author/declan-butler
[3] http://admin.indiaenvironmentportal.org.in/category/journal/nature
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/medical-research
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drug-industry
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/tropical-diseases
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/international-cooperation
[10] http://admin.indiaenvironmentportal.org.in/category/thesaurus/research
[11] http://admin.indiaenvironmentportal.org.in/category/thesaurus/patents
[12] http://admin.indiaenvironmentportal.org.in/category/thesaurus/diseases